2016-4-4: Canadian experts approve continued use of 2,4-D

[fullwidth background_color=”” background_image=”” background_parallax=”none” enable_mobile=”no” parallax_speed=”0.3″ background_repeat=”no-repeat” background_position=”left top” video_url=”” video_aspect_ratio=”16:9″ video_webm=”” video_mp4=”” video_ogv=”” video_preview_image=”” overlay_color=”” overlay_opacity=”0.5″ video_mute=”yes” video_loop=”yes” fade=”no” border_size=”0px” border_color=”” border_style=”” padding_top=”20″ padding_bottom=”20″ padding_left=”” padding_right=”” hundred_percent=”no” equal_height_columns=”no” hide_on_mobile=”no” menu_anchor=”” class=”” id=””][title size=”1″ content_align=”center” style_type=”underline solid” sep_color=”#000000″ margin_top=”” margin_bottom=”” class=”” id=””]

Canadian experts approve continued use of 2,4-D

[/title][fusion_text]Monday, April 4th 2016

Canadian health experts have determined that “registered products containing 2,4-D are acceptable for continued registration” under current use conditions, painting a sharp contrast to decisions made by some other governments. The decision by Health Canada’s Pest Management Regulatory Agency (PMRA) comes as part of a special review, triggered in part by Norway’s decision in 2000 to prohibit the use of products containing 2,4-D. The conclusion is consistent with the PMRA’s previous reviews, including the re-evaluation decisions in 2005, 2007, 2008, and 2013. The PMRA review determined that all forms of 2,4-D are not mutagenic or genotoxic and that “the overall weight of evidence indicates that 2,4-D is not carcinogenic in rats, mice, and dogs.” In addition to the toxicity studies in animals, the PMRA considered expert assessments from numerous epidemiological studies on human exposure. In addition, the PMRA did not find any concerns related to the environment. The PMRA will now accept written comments on the review decision for the next 45 days.

[/fusion_text][/fullwidth]